VivoSim Labs, Inc. (VIVS)
1.45
-0.08
(-5.23%)
USD |
NASDAQ |
Apr 10, 16:00
1.45
0.00 (0.00%)
Pre-Market: 20:00
VivoSim Labs EPS Diluted (Quarterly) : -1.032 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ResMed, Inc. | 2.682 |
| Aprea Therapeutics, Inc. | -0.3194 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.691M |
| Revenue (Quarterly) | 0.026M |
| Total Expenses (Quarterly) | 2.717M |
| Enterprise Value | 0.2937M |
| Gross Profit Margin (Quarterly) | -100.0% |
| Profit Margin (Quarterly) | -10.35K% |
| Earnings Yield | 32.12% |
| Normalized Earnings Yield | 32.11 |